Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intravenous LIGNOcaine for the POstoperative Sore Throat
Sponsor: University of Malaya
Summary
Patients often encounter unpleasant sore throat after surgery when wake up from general anaesthesia and pulling off breathing tube. Lignocaine is a medication used in anaesthesia for the properties of analgesia and anti-inflammation. Other studies suggested that lignocaine spray/ gel can reduce the postoperative sore throat after extubation in patients undergoing surgery. However, it can reduce the gag reflex, resulting in higher risk of aspiration after surgery. Therefore, this randomized, double-blind, placebo-controlled trial is designed to determine whether giving intravenous lignocaine toward the end of the surgery before extubation can reduce postoperative sore throat and discomfort after surgery. It is hypothesized that intravenous lignocaine can reduce postoperative sore throat in patients undergoing general anaesthesia.
Official title: Intravenous LIGNOcaine for the POstoperative Sore Throat: A Double-blinded Randomised Placebo-controlled Trial (LIGNO-POST Trial)
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
398
Start Date
2027-01-01
Completion Date
2027-12-31
Last Updated
2026-11-13
Healthy Volunteers
No
Conditions
Interventions
Intravenous lignocaine
IV lignocaine 1.5 mg/kg, calculated on lean body weight (LBW).
Normal Saline (0.9% NaCl)
0.9% normal saline
Locations (1)
Universiti Malaya Medical Centre
Kuala Lumpur, Kuala Lumpur, Malaysia